Last reviewed · How we verify
Activated Charcoal with Sorbitol
Activated charcoal adsorbs toxins and excess gases in the gastrointestinal tract, while sorbitol acts as a laxative to facilitate their removal.
Activated charcoal adsorbs toxins and excess gases in the gastrointestinal tract, while sorbitol acts as a laxative to facilitate their removal. Used for Management of acute poisoning, Relief of bloating and gas.
At a glance
| Generic name | Activated Charcoal with Sorbitol |
|---|---|
| Sponsor | Bristol-Myers Squibb |
| Drug class | Gastrointestinal adsorbent and laxative |
| Modality | Small molecule |
| Therapeutic area | Gastroenterology |
| Phase | Phase 1 |
Mechanism of action
Activated charcoal has a high adsorption capacity due to its porous structure, which allows it to bind to a wide range of toxins and prevent their absorption into the bloodstream. Sorbitol, a sugar alcohol, draws water into the intestines, softening stools and promoting bowel movements, thus aiding in the elimination of adsorbed substances.
Approved indications
- Management of acute poisoning
- Relief of bloating and gas
Common side effects
- Diarrhea
- Nausea
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Activated Charcoal with Sorbitol CI brief — competitive landscape report
- Activated Charcoal with Sorbitol updates RSS · CI watch RSS
- Bristol-Myers Squibb portfolio CI